Both in Biotechnology
REGENXBIO vs C4 Therapeutics
Over the past year RGNX returned −36.4% and CCCC returned +29.4%; their daily moves had a correlation of 0.29.
RGNX −36.4% CCCC +29.4%Growth of $1, one year, split-adjusted
| Metric | RGNX | CCCC |
|---|---|---|
| Price | $7.63 | $3.21 |
| Market cap | $503.7M | $394.9M |
| Today | +6.56% | 0.00% |
| 1 month | −1.7% | +7.4% |
| 6 months | −17.2% | +8.1% |
| Year to date | −47.0% | +68.1% |
| 1 year | −40.3% | +23.0% |
| Revenue growth (YoY) | +405.7% | +2.8% |
| Gross margin | 99.0% | 100.0% |
| Net margin | 21.0% | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | 11.3× |
| Net cash | $105.5M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 87.1% | 65.3% |
| Short % of float | 19.4% | 43.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).